학술논문

Cancer medicine: a missed opportunity.
Document Type
Letter
Source
Lancet. 4/18/2020, Vol. 395 Issue 10232, p1257-1258. 2p.
Subject
*CANCER
*DRUGS
Language
ISSN
0140-6736
Abstract
Richard Horton's Comment on the broken promise of cancer medicine[1] inspired us to provide another perspective on the issue. As patients, we welcomed the World Health Assembly resolution on cancer prevention and control[3] and the related 2018 WHO Technical Report addressing the pricing of cancer medicines.[4] This report[4] comprehensively addresses pricing approaches and the effects on availability and affordability of cancer treatment. Across the spectrum of stakeholders there are different perspectives on how best to treat cancer, and providing evidence for patient-centred care continuum might help build a consensus. [Extracted from the article]